Global Blood Plasma Fractionation Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Blood Plasma Fractionation market size will reach 37,127 Million USD in 2025 and is projected to reach 63,505 Million USD by 2032, with a CAGR of 7.97% (2025-2032). Notably, the China Blood Plasma Fractionation market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Blood plasma fractionation is the process of separating different components of blood plasma and purifying them into therapeutic products. It is a complex and highly technical process, involving the use of different separation technologies, such as chromatography, centrifugation, filtration, and precipitation. The goal of plasma fractionation is to isolate plasma proteins, such as albumin, immunoglobulins, and clotting factors, which can be used to treat a variety of medical conditions. These proteins are used to produce medications that treat autoimmune diseases, bleeding disorders, and immunodeficiency disorders. Plasma fractionation has revolutionized modern medicine, providing patients with life-saving therapies and medicines.
The major global suppliers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Biological Engineering, Tiantan Biological Products, Boya Bio-Pharmaceutical, Shuanglin Bio-pharmacy, Yuanda Shuyang Pharmaceutical, Weiguang Biological Products, Nanyue Biopharmaceutical, KM Biologics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Blood Plasma Fractionation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Blood Plasma Fractionation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Blood Plasma Fractionation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Blood Plasma Fractionation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Blood Plasma Fractionation Include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Biological Engineering
Tiantan Biological Products
Boya Bio-Pharmaceutical
Shuanglin Bio-pharmacy
Yuanda Shuyang Pharmaceutical
Weiguang Biological Products
Nanyue Biopharmaceutical
KM Biologics
Blood Plasma Fractionation Product Segment Include:
Immune Globulin
Coagulation Factor
Albumin
Others
Blood Plasma Fractionation Product Application Include:
Hospital
Retail Pharmacy
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Blood Plasma Fractionation Industry PESTEL Analysis
Chapter 3: Global Blood Plasma Fractionation Industry Porter's Five Forces Analysis
Chapter 4: Global Blood Plasma Fractionation Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Blood Plasma Fractionation Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Blood Plasma Fractionation Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Blood Plasma Fractionation Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Blood Plasma Fractionation market size will reach 37,127 Million USD in 2025 and is projected to reach 63,505 Million USD by 2032, with a CAGR of 7.97% (2025-2032). Notably, the China Blood Plasma Fractionation market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Blood plasma fractionation is the process of separating different components of blood plasma and purifying them into therapeutic products. It is a complex and highly technical process, involving the use of different separation technologies, such as chromatography, centrifugation, filtration, and precipitation. The goal of plasma fractionation is to isolate plasma proteins, such as albumin, immunoglobulins, and clotting factors, which can be used to treat a variety of medical conditions. These proteins are used to produce medications that treat autoimmune diseases, bleeding disorders, and immunodeficiency disorders. Plasma fractionation has revolutionized modern medicine, providing patients with life-saving therapies and medicines.
The major global suppliers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Biological Engineering, Tiantan Biological Products, Boya Bio-Pharmaceutical, Shuanglin Bio-pharmacy, Yuanda Shuyang Pharmaceutical, Weiguang Biological Products, Nanyue Biopharmaceutical, KM Biologics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Blood Plasma Fractionation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Blood Plasma Fractionation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Blood Plasma Fractionation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Blood Plasma Fractionation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Blood Plasma Fractionation Include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Biological Engineering
Tiantan Biological Products
Boya Bio-Pharmaceutical
Shuanglin Bio-pharmacy
Yuanda Shuyang Pharmaceutical
Weiguang Biological Products
Nanyue Biopharmaceutical
KM Biologics
Blood Plasma Fractionation Product Segment Include:
Immune Globulin
Coagulation Factor
Albumin
Others
Blood Plasma Fractionation Product Application Include:
Hospital
Retail Pharmacy
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Blood Plasma Fractionation Industry PESTEL Analysis
Chapter 3: Global Blood Plasma Fractionation Industry Porter's Five Forces Analysis
Chapter 4: Global Blood Plasma Fractionation Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Blood Plasma Fractionation Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Blood Plasma Fractionation Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Blood Plasma Fractionation Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Blood Plasma Fractionation Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Blood Plasma Fractionation Product by Type
- 1.2.1 Immune Globulin
- 1.2.2 Coagulation Factor
- 1.2.3 Albumin
- 1.2.4 Others
- 1.3 Blood Plasma Fractionation Product by Application
- 1.3.1 Hospital
- 1.3.2 Retail Pharmacy
- 1.3.3 Other
- 1.4 Global Blood Plasma Fractionation Market Size Analysis (2020-2032)
- 1.5 Blood Plasma Fractionation Market Development Status and Trends
- 1.5.1 Blood Plasma Fractionation Industry Development Status Analysis
- 1.5.2 Blood Plasma Fractionation Industry Development Trends Analysis
- 2 Blood Plasma Fractionation Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Blood Plasma Fractionation Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Blood Plasma Fractionation Market Analysis by Country
- 4.1 Global Blood Plasma Fractionation Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Blood Plasma Fractionation Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Blood Plasma Fractionation Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.5 China Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.6 France Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.14 India Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Blood Plasma Fractionation Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Blood Plasma Fractionation Market Revenue by Key Suppliers (2021-2025)
- 5.2 Blood Plasma Fractionation Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Blood Plasma Fractionation Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Blood Plasma Fractionation Market Analysis by Type
- 6.1 Global Blood Plasma Fractionation Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Blood Plasma Fractionation Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Takeda
- 7.1.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Takeda Blood Plasma Fractionation Product Portfolio
- 7.1.3 Takeda Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 CSL
- 7.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CSL Blood Plasma Fractionation Product Portfolio
- 7.2.3 CSL Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Grifols
- 7.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Grifols Blood Plasma Fractionation Product Portfolio
- 7.3.3 Grifols Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Octapharma
- 7.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Octapharma Blood Plasma Fractionation Product Portfolio
- 7.4.3 Octapharma Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Kedrion
- 7.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Kedrion Blood Plasma Fractionation Product Portfolio
- 7.5.3 Kedrion Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 LFB Group
- 7.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 LFB Group Blood Plasma Fractionation Product Portfolio
- 7.6.3 LFB Group Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Biotest
- 7.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Biotest Blood Plasma Fractionation Product Portfolio
- 7.7.3 Biotest Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 BPL
- 7.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 BPL Blood Plasma Fractionation Product Portfolio
- 7.8.3 BPL Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 RAAS
- 7.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 RAAS Blood Plasma Fractionation Product Portfolio
- 7.9.3 RAAS Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 CBPO
- 7.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 CBPO Blood Plasma Fractionation Product Portfolio
- 7.10.3 CBPO Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Hualan Biological Engineering
- 7.11.1 Hualan Biological Engineering Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Hualan Biological Engineering Blood Plasma Fractionation Product Portfolio
- 7.11.3 Hualan Biological Engineering Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Tiantan Biological Products
- 7.12.1 Tiantan Biological Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Tiantan Biological Products Blood Plasma Fractionation Product Portfolio
- 7.12.3 Tiantan Biological Products Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Boya Bio-Pharmaceutical
- 7.13.1 Boya Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Boya Bio-Pharmaceutical Blood Plasma Fractionation Product Portfolio
- 7.13.3 Boya Bio-Pharmaceutical Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Shuanglin Bio-pharmacy
- 7.14.1 Shuanglin Bio-p
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
